ABUS vs CHRW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ABUS

55.9
AI Score
VS
CHRW Wins

CHRW

61.8
AI Score

Investment Advisor Scores

ABUS

56score
Recommendation
HOLD

CHRW

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABUS CHRW Winner
Revenue 180.44M 14.31B CHRW
Net Income 223.67M 532.49M CHRW
Net Margin 124.0% 3.7% ABUS
Operating Income 152.45M 703.24M CHRW
ROE 260.8% 33.7% ABUS
ROA 65.8% 8.3% ABUS
Total Assets 339.70M 6.39B CHRW
Cash 264.19M 193.13M ABUS
Current Ratio 1.40 1.34 ABUS

Relative Price Performance (Last 90 Days)

ABUS 1M: -5.8% · 3M: -15.5% CHRW 1M: -4.0% · 3M: -11.3%

Current Technical Phase

ABUS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $3.87

CHRW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $132.42

Fundamentals Snapshot

Metric ABUS CHRW
Market Cap — —
Forward P/E -34.4 17.3
Trailing P/E 4.7 22.5
Revenue (TTM) — —
Revenue Growth -0.9% 0.3%
Gross Margin 0.9% 0.1%
Operating Margin -5.7% 0.1%
EPS 0.79 5.73
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, CHRW is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.